Source:http://linkedlifedata.com/resource/pubmed/id/16969028
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2006-9-13
|
pubmed:abstractText |
A 69-year-old woman had a 7 x 6 cm tumor on her left breast with ipsilateral axillary lymph node swelling and multiple liver metastases as detected on CT scan (T 3 N 2 M 1 b, Stage IV). Core needle biopsy and immunohistochemistry of breast tumor showed invasive ductal carcinoma with negative hormone receptor and overexpression of HER 2. After a treatment failure of 3 months weekly trastuzumab monotherapy, a combination of bi-weekly trastuzumab and paclitaxel (weekly 6, bi-weekly 9 courses), was given. Tumor markers became negative 4 months later, and multiple liver nodules, breast tumor and axillary nodes completely disappeared 9 months later. Breast surgery was avoided, and CR was maintained more than 8 months only with bi-weekly trastuzumab. From the standpoint of the patient's convenience,a bi-weekly schedule of trastuzumab and paclitaxel could be a promising treatment choice for metastatic breast cancer.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/trastuzumab
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0385-0684
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1297-300
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16969028-Aged,
pubmed-meshheading:16969028-Antibodies, Monoclonal,
pubmed-meshheading:16969028-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:16969028-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16969028-Breast Neoplasms,
pubmed-meshheading:16969028-Carcinoma, Ductal, Breast,
pubmed-meshheading:16969028-Drug Administration Schedule,
pubmed-meshheading:16969028-Female,
pubmed-meshheading:16969028-Humans,
pubmed-meshheading:16969028-Liver Neoplasms,
pubmed-meshheading:16969028-Paclitaxel,
pubmed-meshheading:16969028-Receptor, erbB-2,
pubmed-meshheading:16969028-Remission Induction
|
pubmed:year |
2006
|
pubmed:articleTitle |
[Markedly effective regimen using bi-weekly trastuzumab and paclitaxel in an advanced breast cancer with multiple liver metastases].
|
pubmed:affiliation |
Dept. of Breast Surgery, Sagara Hospital.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|